Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation

NCT00372333 is registered in ClinicalTrials.gov with IDEA AG as lead sponsor.

NCT NCT00372333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation
Lead sponsor
IDEA AG
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
April 30, 2008
Enrollment
491 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

joint pain, musculoskeletal pain, soft tissue inflammation in designated target area(s), stiffness